These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 34052)
1. Antihypertensive effects of a combination of a diuretic and a beta-adrenoceptor blocking agent in conscious, renal hypertensive dogs. Himori N; Ishimori T; Izumi A; Hisatomi M; Hayakawa S Jpn J Pharmacol; 1978 Dec; 28(6):811-8. PubMed ID: 34052 [No Abstract] [Full Text] [Related]
2. A further study on antihypertensive action of beta-adrenoceptor blocking agents in conscious, renal hypertensive dogs. Himori N; Ishimori T; Taira N Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):115-27. PubMed ID: 44454 [TBL] [Abstract][Full Text] [Related]
3. Effects of beta-adrenoceptor blocking agents, pindolol, alprenolol and practolol on blood pressure and heart rate in conscious renal hypertensive dogs. Himori N; Ishimori T; Izumi A; Hiramatsu Y Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):152-65. PubMed ID: 15525 [TBL] [Abstract][Full Text] [Related]
4. SD-3211, a novel benzothiazine calcium antagonist, alone and in combination with a beta-adrenoceptor antagonist, produces antihypertensive effects without affecting heart rate and atrioventricular conduction in conscious renal hypertensive dogs. Kageyama M; Nishimura K; Takada T; Miyawaki N; Yamauchi H J Cardiovasc Pharmacol; 1991 Jan; 17(1):102-7. PubMed ID: 1708042 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats. Inagaki O; Sudoh K; Shibasaki M; Nakagawa C; Honda K J Cardiovasc Pharmacol; 1994 Nov; 24(5):794-802. PubMed ID: 7532758 [TBL] [Abstract][Full Text] [Related]
6. A comparative trial of fixed ratio beta-adrenoceptor blocker and diuretic combination products in moderate hypertension. Watt SJ; Lee MR Pharmatherapeutica; 1980; 2(7):487-93. PubMed ID: 6111083 [TBL] [Abstract][Full Text] [Related]
8. Long term experience of felodipine in combination with beta-blockade and diuretics in refractory hypertension. Collste P; Danielsson M; Elmfeldt D; Feleke E; Gelin A; Hedner T; Rydén L Drugs; 1985; 29 Suppl 2():124-30. PubMed ID: 2859184 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of severe arterial hypertension with propyldazine (ISF 2123) associated with a diuretic and a beta-blocking agent]. Angelino PF; Lavezzaro G; Carnovali M Minerva Cardioangiol; 1979 Mar; 27(3):113-8. PubMed ID: 37462 [No Abstract] [Full Text] [Related]
10. [Antihypertensive therapy using beta receptor blockers]. Meurer KA Dtsch Med Wochenschr; 1975 Oct; 100(42):2161-2. PubMed ID: 240664 [No Abstract] [Full Text] [Related]
11. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 1st communication: antihypertensive effects of valsartan in hypertensive models. Yamamoto S; Hayashi N; Kometani M; Nakao K; Inukai T Arzneimittelforschung; 1997 May; 47(5):604-12. PubMed ID: 9205773 [TBL] [Abstract][Full Text] [Related]
12. [Field study: long-term antihypertensive therapy with the beta blocker nadolol in a once-a-day dosage - an outpatient study of Swiss medical practices]. Bertel O; Conen D; Renggli I Schweiz Rundsch Med Prax; 1983 Feb; 72(8):264-8. PubMed ID: 6132374 [No Abstract] [Full Text] [Related]
13. Single-agent and combination therapy of essential hypertension. Weber MA; Drayer JI Am Heart J; 1984 Aug; 108(2):311-6. PubMed ID: 6147077 [TBL] [Abstract][Full Text] [Related]
14. [Fixed-dose combination therapy: reduction of side effects with enhanced tolerance and antihypertensive efficacy]. González Maqueda I; Gómez Guindal JA; González Lama I Rev Esp Cardiol; 1999; 52 Suppl 3():59-72. PubMed ID: 10614151 [TBL] [Abstract][Full Text] [Related]
15. Special considerations for antihypertensive agents in dialysis patients. Redon J; Martinez F; Cheung AK Blood Purif; 2010; 29(2):93-8. PubMed ID: 20093810 [TBL] [Abstract][Full Text] [Related]
16. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease. Jensen J; Henik RA; Brownfield M; Armstrong J Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564 [TBL] [Abstract][Full Text] [Related]
17. Hypotensive action of propranolol and a new beta-blocking agent, D-32 in conscious normotensive and renal hypertensive dogs. Himori N; Izumi A; Hiramatsu Y Arch Int Pharmacodyn Ther; 1976 Mar; 220(1):4-18. PubMed ID: 8021 [TBL] [Abstract][Full Text] [Related]